Abbott Laboratories News

AbbVie files appeal contesting landmark $448 million antitrust win for Federal Trade Commission

By Mary Ann Magnell | Aug 23, 2018

PHILADELPHIA (Legal Newsline) — Defendants AbbVie Inc., Abbott Laboratories and Unimed Pharmaceuticals LLC filed an appeal on Aug. 6 in a U.S. District Court in response to the final judgment in an antitrust case that found in favor of the Federal Trade Commission.

Missouri SC upholds damages award of nearly $40 million in Depakote lawsuit

By Jessica Karmasek | Sep 15, 2017

Defendant Abbott Laboratories Inc. appealed the City of St. Louis Circuit Court’s judgment awarding plaintiff Maddison Schmidt $15 million in compensatory damages and $23 million in punitive damages for her personal injury claim. Schmidt was born with spina bifida and other birth defects.

Class action filed over Similac, alleges product contains GMOs

By Mike Torres | May 26, 2017

SAN FRANCISCO (Legal Newsline) — Two consumers have filed a class action lawsuit against Abbott Labs, alleging breach of implied warranty, breach of warranty, fraud, negligence and negligent misrepresentation.

Abbott's attempt to exit Alere merger could set precedent

By Tabitha Fleming | Feb 16, 2017

WILMINGTON, Del. (Legal Newsline) – Pending litigation in Delaware between Abbott Laboratories and Alere may set new precedents in the state if the court agrees to let Abbott back out of the proposed merger.

Add lawsuit filed over alleged escheatment of shares to Alere’s list of woes

By Jessica Karmasek | Feb 6, 2017

A Swiss doctor filed his lawsuit against Alere Inc. and Computershare Limited in the U.S. District Court for the District of Delaware last month. In 2008, the plaintiff acquired 11,931 shares in Alere, and held those shares until, he claims, they were wrongfully escheated, or seized by the State of Delaware, in February 2013.

Company that submitted Medicare claims for the deceased claims it was targeted by CMS

By Karen Kidd | Jan 3, 2017

WALTHAM, Mass. (Legal Newsline) – An appeal by health diagnostics company Alere to get Medicare billing privileges reinstated for a subsidiary diabetes unit, Arriva Medical, claims that the unit was targeted by the Centers for Medicare & Medicaid Services (CMS) to clear an administrative backlog, according to an Alere press release.

Alere's troubles, stock drop leave Abbott Labs attempting to terminate merger

By John O'Brien | Dec 13, 2016

WILMINGTON,Del. (Legal Newsline) – Global health care company Abbott Laboratories is asking a Delaware court to terminate its proposed merger with Alere because, it says, the company has been so poorly run that it no longer resembles its former self.

Consolidated complaint filed in securities fraud class action against diagnostics company Alere

By Jessica Karmasek | Oct 20, 2016

The plaintiffs in the proposed class action, originally filed in a Massachusetts federal court in April, argue they purchased Alere Inc. common stock and suffered damages as a result of the company’s alleged federal securities law violations and false and/or misleading statements and/or material omissions amid a failed merger with Abbott Laboratories Inc.

Makers of Clearblue pregnancy test sued over alleged false claims about product

By Robbie Hargett | Dec 15, 2015

LOS ANGELES (Legal Newsline) – A California woman is suing several consumer diagnostic products companies over allegedly misrepresenting the efficacy of a certain pregnancy test product.

The Record Network